Literature DB >> 33164645

Matrine Inhibitory Effect on Self-renewal and Re-sensitization of 5-FU Resistant NSCLC Stem Cells were through Let-7b dependent Downregulation of CCND1.

Xiang Li1, Meng Wang1, Ning Du1, Ting Liang2,3, Guo-Dong Xiao1,4, Kai Li1, Ji-Chang Wang5, Chong-Wen Xu6, Zi-Yang Peng1, Shou-Ching Tang7, Xin Sun1.   

Abstract

Matrine is one of the major alkaloids extracted from Sophora flavescens Ait of the traditional Chinese medicine, was the main chemical ingredient of compounds of Kushen injection. The Matrine is considered as a promising therapeutic agent for curing nonsmall cell lung cancer (NSCLC), used either alone or combined with chemotherapeutic agents. In the present study, we focused on the possible roles of Matrine exerted on the self-renewal ability of stem-like cells of the NSCLC group, as well as the cytotoxicity of chemotherapeutic agents, in vitro and in vivo. Here we reported that Matrine inhibits cancer stem-like cell (CSC) properties through upregulation of Let-7b and suppression of the Wnt pathway. Overexpression of Let-7b suppressed the ability of tumorsphere formation, decreased Wnt pathway activation through inhibiting its transcriptional activity in lung CSCs. Further studies revealed that Let-7b directly targeted CCND1 and decreased its expression, whereas Matrine increased Let-7b levels and followed by inactivation of the CCND1/Wnt signaling pathway and inhibition of EMT, which was characterized by loss of epithelial markers and acquisition of a mesenchymal phenotype in lung CSCs. What is more, we found that Matrine increased Let-7b level in an endoribonuclease DICER1-dependent manner. And xenografts in nude mice evidenced that Matrine increased the sensitivity of lung CSCs to 5-FU and inhibited the accumulation of CCND1 in tumor tissues induced by 5-FU. Taken together, these data illustrate the role of Let-7b in regulating lung CSCs traits and DICER1/let-7/CCND1 axis in Matrine or in combination with 5-FU intervention of lung CSCs' expansion, helping to fulfill the anti-cancer action of Matrine.

Entities:  

Keywords:  Matrine; NSCLC; cancer stem cells; division manners; therapy resistance

Year:  2020        PMID: 33164645      PMCID: PMC7751667          DOI: 10.1080/15384101.2020.1838791

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  28 in total

1.  Traditional Chinese medicine as adjunctive therapy improves the long-term survival of lung cancer patients.

Authors:  Yueh-Hsiang Liao; Chia-Ing Li; Cheng-Chieh Lin; Jaung-Geng Lin; Jen-Huai Chiang; Tsai-Chung Li
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-12       Impact factor: 4.553

2.  Let-7c blocks estrogen-activated Wnt signaling in induction of self-renewal of breast cancer stem cells.

Authors:  X Sun; C Xu; S-C Tang; J Wang; H Wang; P Wang; N Du; S Qin; G Li; S Xu; Z Tao; Dapeng Liu; H Ren
Journal:  Cancer Gene Ther       Date:  2016-03-18       Impact factor: 5.987

3.  A novel matrine derivative WM622 inhibits hepatocellular carcinoma by inhibiting PI3K/AKT signaling pathways.

Authors:  Xiao Sun; Xiao-Bin Zhuo; Yi-Ping Hu; Xuan Zheng; Qing-Jie Zhao
Journal:  Mol Cell Biochem       Date:  2018-03-12       Impact factor: 3.396

4.  Matrine inhibits the adhesion and migration of BCG823 gastric cancer cells by affecting the structure and function of the vasodilator-stimulated phosphoprotein (VASP).

Authors:  Jing-wei Zhang; Ke Su; Wen-tao Shi; Ying Wang; Peng-chao Hu; Yang Wang; Lei Wei; Jin Xiang; Fang Yang
Journal:  Acta Pharmacol Sin       Date:  2013-05-20       Impact factor: 6.150

5.  Matrine inhibiting pancreatic cells epithelial-mesenchymal transition and invasion through ROS/NF-κB/MMPs pathway.

Authors:  Minna Huang; Wen Xin
Journal:  Life Sci       Date:  2017-11-16       Impact factor: 5.037

Review 6.  The let-7 family of microRNAs.

Authors:  Sarah Roush; Frank J Slack
Journal:  Trends Cell Biol       Date:  2008-09-04       Impact factor: 20.808

7.  DICER1 regulated let-7 expression levels in p53-induced cancer repression requires cyclin D1.

Authors:  Xin Sun; Shou-Ching Tang; Chongwen Xu; Chenguang Wang; Sida Qin; Ning Du; Jian Liu; Yiwen Zhang; Xiang Li; Gang Luo; Jie Zhou; Fei Xu; Hong Ren
Journal:  J Cell Mol Med       Date:  2015-02-20       Impact factor: 5.310

8.  The 2014 Nucleic Acids Research Database Issue and an updated NAR online Molecular Biology Database Collection.

Authors:  Xosé M Fernández-Suárez; Daniel J Rigden; Michael Y Galperin
Journal:  Nucleic Acids Res       Date:  2013-12-06       Impact factor: 16.971

Review 9.  Hallmarks of cancer stem cell metabolism.

Authors:  Patricia Sancho; David Barneda; Christopher Heeschen
Journal:  Br J Cancer       Date:  2016-05-24       Impact factor: 7.640

Review 10.  Wnt signaling in cancer.

Authors:  T Zhan; N Rindtorff; M Boutros
Journal:  Oncogene       Date:  2016-09-12       Impact factor: 9.867

View more
  2 in total

Review 1.  Matrine Exerts Pharmacological Effects Through Multiple Signaling Pathways: A Comprehensive Review.

Authors:  Yingda Lin; Qiu Du; Fuming He; Ling Wu; Yuan Xu
Journal:  Drug Des Devel Ther       Date:  2022-03-01       Impact factor: 4.162

2.  M6A associated TSUC7 inhibition contributed to Erlotinib resistance in lung adenocarcinoma through a notch signaling activation dependent way.

Authors:  Kai Li; Zi-Yang Peng; Shan Gao; Qing-Shi Wang; Rui Wang; Xiang Li; Guo-Dong Xiao; Jing Zhang; Hong Ren; Shou-Ching Tang; Xin Sun
Journal:  J Exp Clin Cancer Res       Date:  2021-10-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.